Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference

Rhea-AI Summary

Xenon Pharmaceuticals Inc. (Nasdaq:XENE) will present at the 2024 RBC Capital Markets Global Healthcare Conference. The event will take place on May 14-15, 2024, in New York, NY. Presenters include Ian Mortimer, President and CEO, and Sherry Aulin, CFO. The company focuses on neuroscience, aiming to develop therapeutics for neurological and psychiatric disorders. Xenon's live webcast will be available on their website for replay.

VANCOUVER, British Columbia, May 07, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced that the company will present at the 2024 RBC Capital Markets Global Healthcare Conference taking place May 14-15, 2024 in New York, NY.

Fireside Chat Presentation Details:
Date:	Tuesday, May 14, 2024
Time:	3:35 pm Eastern Time
Webcast:	Register here
Presenters:	Ian Mortimer, President and Chief Executive Officer Sherry Aulin, Chief Financial Officer

A live webcast of the company presentation will be available on the “Investors” section of Xenon's website and posted for replay following the event. The above listed dates and times are subject to change.

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals (Nasdaq:XENE) is a neuroscience-focused biopharmaceutical company committed to discovering, developing, and commercializing innovative therapeutics to improve the lives of people living with neurological and psychiatric disorders. We are advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. For more information, please visit www.xenon-pharma.com.

“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

Contacts:
For Investors:
Chad Fugere
Vice President, Investor Relations
(857) 675-7275
investors@xenon-pharma.com

For Media:
Jodi Regts
Xenon Corporate Affairs
(604) 484-3353
media@xenon-pharma.com

FAQ

When is Xenon Pharmaceuticals presenting at the 2024 RBC Capital Markets Global Healthcare Conference?

Xenon Pharmaceuticals will present at the 2024 RBC Capital Markets Global Healthcare Conference on May 14-15, 2024.

Who are the presenters from Xenon Pharmaceuticals at the conference?

The presenters from Xenon Pharmaceuticals at the conference are Ian Mortimer, President and CEO, and Sherry Aulin, CFO.

What is Xenon Pharmaceuticals focusing on?

Xenon Pharmaceuticals focuses on neuroscience and aims to develop therapeutics for neurological and psychiatric disorders.

Where can I watch the live webcast of Xenon Pharmaceuticals' presentation?

The live webcast of Xenon Pharmaceuticals' presentation will be available on their website.